Cargando…
Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
Primary immunodeficiency diseases (PIDs) are rare diseases that are characterized by genetic mutations that damage immunological function, defense, or both. Some of these rare diseases are caused by aberrations in the normal development of natural killer cells (NKs) or affect their lytic synapse. Th...
Autores principales: | Eguizabal, C., Herrera, L., Inglés-Ferrándiz, M., Izpisua Belmonte, J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590703/ https://www.ncbi.nlm.nih.gov/pubmed/33109263 http://dx.doi.org/10.1186/s13287-020-01964-5 |
Ejemplares similares
-
Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
por: Eguizabal, C., et al.
Publicado: (2021) -
Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
por: Herrera, Lara, et al.
Publicado: (2021) -
A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells
por: Romayor, Irene, et al.
Publicado: (2022) -
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021) -
Age-related cardiopathies gene editing
por: Song, Moshi, et al.
Publicado: (2019)